With our proposed multimodal human lifestyle intervention study, containing dietary and exercise components, we aim to improve (combinations of) immuno-metabolic health (blood glucose, glycoprotein acetyls, very low density lipoprotein diameter),…
ID
Source
Brief title
Condition
- Other condition
Synonym
Health condition
veroudering (immunometabool, darmgezondheid, spiergezondheid/functioneren)
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The main study endpoints are the intervention effects on metabolic outcomes
(glucose, glycoprotein acetyl, very low-density lipoprotein diameter), faecal
bifidobacterial count, time for the 5-times chair stand test and appendicular
lean mass in the intervention groups.
Secondary outcome
The secondary study parameters are:
- Muscle function: Short Physical Performance Battery (SPPB), Timed Up and Go
test (TUG), 6-minute walking test (6MWT), 1 repetition maximum test (1RM) as
measured on exercise machines
- Body composition: DEXA whole body and regional lean and fat mass
- Immuno-metabolic health: haemoglobin A1c (Hba1c), insulin, blood pressure
- Specifically for the TKR group, additional measures will be performed to
assess muscle mass and overall functioning following TKR-surgery: a
single-slice CT-scans midway the upper legs, and the Western Ontario and
McMaster Universities Arthritis Index (WOMAC).
- Response heterogeneity (and potential explaining factors) will be studied
using the above primary and secondary parameters and may be studied in the
future in RNA expression, DNA methylation as well as the influence of genetic
variation in the metabolically impaired groups and the reference group and be
compared with such studies in other lifestyle interventions in older adults .
Background summary
Age is the most prominent risk factor for common diseases and multi-morbidity.
And yet it is the biological age of individuals even more than their
chronological age that influences such risk. The diversity in functioning
within the population of older adults suggests that various factors influence
biological age, resulting in substantial differences in (patho)physiological
state and disease risk between individuals of the same chronological age
(heterogeneity). Prominent drivers of biological age have been found in
pathways of energy metabolism and balance (metabolic health), chronic
inflammation and immunity and a central role for muscle and gut health
influencing biological age. Mobility is a major determinant of these drivers
and the physiological state of older people.
Combined lifestyle interventions are expected to beneficially influence
multiple aspects of biological age but the large heterogeneity of older adults
often obscures the effect of interventions. Hence, in order to slow down the
biological ageing process via preclinical or clinical interventions, it is
necessary to first study the effect of human interventions on diverse health
segments of older adults as well as individual older adults. This would allow
for a better understanding of biological factors that explain the heterogeneity
in responses often observed and could eventually lead to interventions better
tailored to segments and individuals.
Study objective
With our proposed multimodal human lifestyle intervention study, containing
dietary and exercise components, we aim to improve (combinations of)
immuno-metabolic health (blood glucose, glycoprotein acetyls, very low density
lipoprotein diameter), gut-health (bifidobacteria), muscle mass (appendicular
lean mass) and physical functioning (5-times chair stand test) in three
different segments of older adults with varying degrees of compromised mobility
or metabolism (>=60 years of age), to study the difference in responsiveness
between mobility segments and heterogeneity in responsiveness of individuals
both within and between mobility segments.
Study design
The parallel, partially random (only in TKR groups) intervention will have a
duration of 12 weeks and includes 3 different intervention groups of older
adults segmented primarily by functional and metabolic status, a control group
of the knee replacement segment, and an active, community-dwelling reference
group representing the healthiest older adults.
Intervention
The intervention consists of a combined exercise and nutritional intervention.
All participants will perform 12 weeks of supervised whole-body resistance type
exercise training; leg press, leg extension, calf raises, chest press, shoulder
press, horizontal row and vertical lateral pull exercise will be performed on
weightlifting machines, 3 days per week. The dietary intervention aims to
attain a diet that comprises sufficient protein (1.5 g/kg bodyweight/day,
distributed as 25-30 g protein per main meal, as well as a pre-sleep intake
moment), vitamin D (800 IU/day), calcium (366 mg/day), and prebiotics and is
otherwise in line with the Dutch Healthy Diet guidelines. To this end,
participants will receive nutritional counselling and will ingest a
protein-vitD-calcium-prebiotic product with breakfast, and a protein-calcium
product before sleep.
Study burden and risks
The intervention groups perform a supervised resistance type exercise program
three times per week, ingest nutritional prototypes twice daily and implement
adjustments of the general diet to increase protein intake and adhere to
general healthy eating guidelines for a total intervention period of 12 weeks.
These types of diets combined with exercise generally benefit muscle, gut and
immuno-metabolic health in older adults and have been assessed to be safe in
general. People for whom this is contraindicated (e.g. with kidney disease) are
excluded. Exercise training bears small risks of injury which will be mitigated
by employing trained professionals and executed one-to-one or in small groups
suitable to the populations, with individual adjustment of the intensity of the
program. It is possible that participants may experience light muscle soreness
induced by unaccustomed exercise, especially at the start of the program.
All groups will have the following measurements taken thrice (screening,
baseline and endpoint measurements): fill out questionnaires and undergo
venepunctures for blood samples, weight and height measured. The following will
be collected twice (baseline, endpoint): collect stool samples, wear
accelerometers, fill out a dietary record, have their waist circumference
measurement taken, perform physical function tests, receive a dual X-ray
absorptiometry scan, have their blood pressure taken and fill in several
questionnaires. The risk of complications from drawing blood is small and
samples will be drawn by trained professionals. There are no complications
associated with the procedure of a DXA scan. The level of radiation emitted
during a DXA is merely a fraction of that emitted during a regular chest X-ray.
All other measurements take time but are not associated with any risks and will
be done under supervision.*
Einthovenweg 20
Leiden 2333ZC
NL
Einthovenweg 20
Leiden 2333ZC
NL
Listed location countries
Age
Inclusion criteria
All participants: age 60 or older, body mass index 18.5-35.0 kg/m2,
community-dwelling, mentally competent (MMSE score 24 or over). Depending on
the group the main additional criteria are: 1) metabolically compromised group:
Metabolomic Mortality Score within the top half of the batch of subjects 60
years and older from and also outside the LLS cohort 2) mobility compromised
group: using a walking aid and/or slow 5-times chair stand test (>15 seconds)
3) total knee replacement groups (intervention group and control group): living
in/or around the areas of Maastricht, Eindhoven, and Venlo/Roermond/Nijmegen
and underwent elective total knee replacement surgery ~6 weeks before start of
study 4) healthy active reference group: meeting the Dutch norms for being
physically active, Metabolic Mortality Score below the top half of of the batch
of subjects 60 years and older from and also outside the LLS cohort
Exclusion criteria
Already using prebiotic fibres or high doses of supplements, contraindications
for using milk/lactose/calcium/vitamin D, engagement in intense physical
activity, (aforementioned criteria are not exclusion criteria for the reference
group), eGFR <30 ml/min/1.73 m2, diseases, conditions or disorders which may
affect the ability to follow the study protocol and which cannot be overcome
with help of a caregiver, current participation in other scientific research
that conflicts with this study, Not signed up to a general practitioner, No
permission to request information from the general practitioner/ treating
specialist(s) about medical history, medication use
Design
Recruitment
metc-ldd@lumc.nl
metc-ldd@lumc.nl
metc-ldd@lumc.nl
metc-ldd@lumc.nl
metc-ldd@lumc.nl
metc-ldd@lumc.nl
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
ClinicalTrials.gov | NCT05354310 |
CCMO | NL76879.058.21 |